| Occurred at admission (n = 17) | Occurred after admission (n = 11) | P* |
Age, MD ± SD, y | 61.4 ± 9.8 | 55.4 ± 10.5 | 0.138 |
Male, n, (%) | 9 (52.9) | 7 (63.6) | 0.054 |
Albumin (g/L) |
|
|
|
baseline | 35.9 ± 4.3 | 35.4 ± 4.6 | 0.802 |
extremum | 31.8 ± 5.3 | 30.7 ± 4.8 | 0.591 |
P# | 0.019 | 0.028 |
|
Alanine aminotransferase × U/L |
|
|
|
baseline | 56.0 (38.0, 89.0) | 21.0 (15.0, 29.0) | 0.000 |
extremum | 66.0 (47.0, 126.0) | 81.0 (68.0, 106.0) | 0.677 |
P# | 0.333 | 0.000 |
|
Aspartate aminotransferase × U/L |
|
|
|
baseline | 55.0 (42.0, 70.0) | 29.0 (21.0, 35.0) | 0.000 |
extremum | 64.0 (47.0, 78.5) | 54.0 (46.0, 62.0) | 0.225 |
P# | 1.000 | 0.004 |
|